Congestive Heart Failure in Children

Jack F Price1

  • 1Department of Pediatrics, Baylor College of Medicine, and Advanced Heart Failure Unit, Texas Children's Hospital, Houston, TX.

Pediatrics in Review
|February 3, 2019
PubMed

Insights

Pediatric heart failure, a common pathway for childhood diseases, requires early diagnosis and treatment to improve outcomes. This review details clinical features, diagnostics, and evidence-based treatments for pediatric heart failure, including acute decompensation.

Area of Science:

  • Pediatrics
  • Cardiology
  • Internal Medicine

Background:

  • Congestive heart failure (CHF) is a critical endpoint for various pediatric conditions, including genetic cardiomyopathies, viral infections, metabolic disorders, and autoimmune diseases.
  • Early recognition and intervention in pediatric CHF are crucial for mitigating symptom severity and potentially altering disease trajectory.

Purpose of the Study:

  • To provide a comprehensive overview of pediatric heart failure.
  • To describe the clinical presentation and diagnostic pathways for pediatric heart failure.
  • To outline evidence-based therapeutic strategies for managing pediatric heart failure across different clinical stages.

Main Methods:

  • This is a review article.
  • It synthesizes current knowledge on pediatric heart failure.
  • Information is gathered from existing literature on clinical characteristics, diagnostics, and treatment.

Main Results:

  • Pediatric heart failure presents diverse clinical features depending on the underlying etiology.
  • Initial diagnostic evaluation involves a systematic approach to identify the cause and assess severity.
  • Treatment strategies are tailored to the clinical stage, encompassing acute decompensation and chronic management.

Conclusions:

  • Effective management of pediatric heart failure hinges on prompt identification and appropriate therapeutic interventions.
  • A thorough understanding of clinical characteristics and diagnostic tools is essential for optimal patient care.
  • Evidence-based treatment, including management of acute decompensated heart failure, can significantly impact outcomes in affected children.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
894
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.5K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
865
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
329
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
963
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
305